Crosstalk between Regnase-1 and -3 shapes mast cell survival and cytokine expression.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 22 04 2024
revised: 17 05 2024
accepted: 22 05 2024
medline: 4 6 2024
pubmed: 4 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

Post-transcriptional regulation of immune-related transcripts by RNA-binding proteins (RBPs) impacts immune cell responses, including mast cell functionality. Despite their importance in immune regulation, the functional role of most RBPs remains to be understood. By manipulating the expression of specific RBPs in murine mast cells, coupled with mass spectrometry and transcriptomic analyses, we found that the Regnase family of proteins acts as a potent regulator of mast cell physiology. Specifically, Regnase-1 is required to maintain basic cell proliferation and survival, whereas both Regnase-1 and -3 cooperatively regulate the expression of inflammatory transcripts upon activation, with

Identifiants

pubmed: 38830770
pii: 7/8/e202402784
doi: 10.26508/lsa.202402784
pii:
doi:

Substances chimiques

Cytokines 0
Ribonuclease, Pancreatic EC 3.1.27.5
regnase-1, mouse EC 3.1.-
Zc3h12a protein, mouse EC 3.1.-
Ribonucleases EC 3.1.-
RNA-Binding Proteins 0
ZC3H12A protein, human EC 3.1.-
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Bataclan et al.

Auteurs

Marian Bataclan (M)

https://ror.org/05gfswd81 Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.

Cristina Leoni (C)

https://ror.org/05gfswd81 Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.

Simone G Moro (SG)

https://ror.org/05gfswd81 Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.

Matteo Pecoraro (M)

https://ror.org/05gfswd81 Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.

Elaine H Wong (EH)

Institute for Immunology, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.

Vigo Heissmeyer (V)

Institute for Immunology, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.
Research Unit Molecular Immune Regulation, Helmholtz Zentrum München, Munich, Germany.

Silvia Monticelli (S)

https://ror.org/05gfswd81 Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland silvia.monticelli@irb.usi.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH